Follow the directions supported by that specific formulation
This will depend on your other medical conditions and any other medications you are taking
GLP-1 Synthesis GLP-1 and GLP-2 were identified in the distal small intestinal mucosa as the product of post-translational processing by prohormone convertase 1/3 (PC1/3) of the proglucagon gene product (9) which in the Islets is processed by PC2 to yield glucagon (75, 87, 97)
Researchers noted that MT-2 also shortened the latency of the first erectile event to occur, concluding that the peptide recruited the central and peripheral melanocortin pathways to achieve this effect [7]
This leads to: Reduced appetite and increased feelings of fullness Slowed gastric emptying , meaning food moves more slowly through the digestive system Improved blood sugar regulation through glucose-dependent insulin secretion Decreased glucagon release , which helps control glucose production Because Wegovy significantly affects the gastrointestinal system, digestive side effects are very common , particularly when starting treatment or increasing the dose
